Conscientia Industrial Co., Ltd

Baricitinib
Baricitinib | CAS 1187594-09-7 API Manufacturer & Supplier in China
Looking for Baricitinib CAS 1187594-09-7?
Conscientia Industrial is Baricitinib API manufacturer & supplier in China, offering ≥98.0% purity, stable industrial supply, and fast global shipping. Request Price, COA, and MSDS from Conscientia Industrial right now.
Product Overview
Baricitinib (CAS 1187594-09-7) is a potent, selective oral Janus kinase (JAK) inhibitor, specifically targeting JAK1 and JAK2 pathways. Within the Pharmaceutical APIs and scientific research fields, this active substance is widely utilized for developing therapeutic formulations that modulate inflammatory and autoimmune cascades by blocking cytokine signaling. As a leading manufacturer of Baricitinib CAS 1187594-09-7 based in China, Conscientia Industrial uses highly optimized synthetic chemical routes to deliver an advanced premium-grade batch profile. Our material strictly adheres to rigorous international technical criteria, making it a reliable choice for global formulation development, commercial production, and pharmaceutical research projects.
Technical Specifications
Product Name: Baricitinib
CAS Number: 1187594-09-7
Category: Pharmaceutical APIs
Quality Standard: In-House Specification
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.42
Appearance: White to off-white powder
Purity (HPLC): ≥99.0%
Single Impurity: ≤0.1%
Water Content: ≤0.5%
Residue on Ignition: ≤0.2%
Heavy Metals: ≤10ppm
Brand: Conscientia Industrial
Country of Origin: China
Availability: In Stock
Pricing: Competitive price based on purchase quantity
Currency: USD
Molecular Structure:

Why Partner with Conscientia Industrial
JAK Inhibitor Synthesis Expertise: Specialized in the complex heterocyclic synthesis required for high-selectivity kinase inhibitors.
Standardized Manufacturing: We Produce Baricitinib in state-of-the-art facilities compliant with GMP guidelines to ensure the highest safety and efficacy.
Technical Quality Control: Our facility utilizes advanced crystallization and synthetic techniques to eliminate chemical impurities from the raw material.
Advanced Analytical Verification: Every single batch of Baricitinib undergoes strict verification using HPLC, LC-MS, and NMR testing protocols to verify structural identity and chemical purity.
Full Technical Documentation: We provide full compliance files, including comprehensive Certificate of Analysis (COA), MSDS, and Method of Analysis (MOA) for Baricitinib CAS 1187594-09-7.
Scalable Production Capacity: Our industrial infrastructure supports variable purchasing scales, successfully handling both smaller clinical trial materials and high-volume commercial bulk manufacturing requirements.
Direct Source Advantage: Working directly with a primary supplier in China grants access to optimal production timelines, competitive commercial rates, and precise engineering support.
Packaging & Storage
Standard Packaging: 100g, 1kg in sealed aluminum bags or custom bulk packaging based on requirements.
Storage Conditions: Store the substance in a well-closed, tight container away from direct heat, high moisture, and intense light sources. Recommended to store at controlled room temperature.
Shelf Life: 24 months from the manufacturing date when stored under correct recommended conditions.
Safety Handling: This is a professional-grade API intended for industrial pharmaceutical production and laboratory research use only.
Our commercial logistics department provides streamlined shipping of Baricitinib CAS 1187594-09-7 worldwide via specialized chemical couriers, reliable air freight systems, and sea freight logistics networks.
Request a Quote & COA for Baricitinib CAS 1187594-09-7 Today.
Featured Peptides 98%+ Purity |
|---|
Tyroservaltide |
µ-Conotoxin GIIIA |
Leconotide |
BPC-157 |
Protirelin Acetate |
Expert Review
Rating: 5/5
★★★★★ Daniel Hughes (QA Director)
The API demonstrates high purity and consistent batch-to-batch quality. It performs well and meets required specifications for our pharmaceutical manufacturing.